Myelin-derived Peptides
Myelin-derived Peptides - Related Videos
18:17
Derivation of Enriched Oligodendrocyte Cultures and Oligodendrocyte/Neuron Myelinating Co-cultures from Post-natal Murine Tissues
0 Views •
Cited by 106 •
2011
This article describes methods to derive enriched populations of murine oligodendrocyte precursor cells (OPCs) in primary culture, which differentiate to produce mature oligodendrocytes (OLs). In addition, this report describes techniques to produce murine myelinating co-cultures by seeding mouse OPCs onto a neurite bed of mouse dorsal root ganglion neurons (DRGNs).
08:48
Peptide-derived Method to Transport Genes and Proteins Across Cellular and Organellar Barriers in Plants
0 Views •
Cited by 15 •
2016
Existing methods for the modification of plants have limited applicability. The novel peptide-derived technology proposed here promises both simplicity and efficiency in the introduction of exogenous protein or genes into the desired intracellular compartments of intact plants.
12:27
In Vitro Phagocytosis of Myelin Debris by Bone Marrow-Derived Macrophages
0 Views •
Cited by 43 •
2017
We present methods to assess the phagocytic capacity of primary murine bone marrow-derived macrophages using fluorescently labeled myelin debris and intracellular lipid droplet staining.
04:59
Evaluating the Intracellular Distribution of Virus-Derived Peptide-Modified Antibody Conjugates
0 Views •
2025
This video demonstrates the process of assessing the intracellular distribution of virus-derived peptide-modified antibody conjugates using confocal microscopy. The viral-derived nuclear localization sequence directs antibody-conjugates within the cytoplasm, confirmed through immunostaining and fluorescence measurement.
01:23
A Gold Staining Technique to Visualize Myelin Reduction in Stressed Mice
0 Views •
2025
Stress impairs oligodendrocyte function, disrupting the lipid-rich myelin sheath surrounding neuronal axons in the medial prefrontal cortex, a brain region regulating emotion.
FAQs
When these peptides bind neuronal receptors such as the Nogo receptor complex, they activate intracellular signaling involving RhoA and Rho-associated kinase. This signaling suppresses cytoskeletal remodeling, the reorganization needed for neurite extension. As a result, neurons face greater difficulty extending processes, helping explain restricted axonal regeneration after central nervous system injury.
RhoA and Rho-associated kinase act as intracellular components that connect receptor activation with changes in neuronal structure. Their signaling reduces cytoskeletal remodeling and neurite extension rather than merely affecting extracellular interactions. Because these pathways influence the physical growth behavior of neurons, they represent important points for studying or blocking inhibitory signaling.
Their effects provide a way to examine communication among oligodendrocytes, neurons, and the injured neural environment. By altering neuronal growth and signaling, the peptides can contribute to conditions that limit repair after spinal cord or brain injury. Studying these interactions links molecular inhibition with the broader cellular context of neural damage and recovery.
The mechanism helps account for why axonal regeneration remains limited after injury to the spinal cord or brain. It also connects myelin-associated signaling with neurite extension, neural plasticity, and functional recovery. This framework allows researchers to relate receptor-driven intracellular inhibition to larger questions about how damaged neural circuits respond and repair.
Research examines how these bioactive fragments affect neuronal growth and signaling, particularly in the setting of spinal cord or brain damage. Investigators can focus on receptor interactions, RhoA and Rho-associated kinase signaling, and the resulting limitation of neurite extension. These perspectives help connect molecular events with impaired regeneration and possible recovery strategies.
The signaling system supports research into approaches that block inhibitory signals, promote neural plasticity, or improve functional recovery. Blocking the relevant pathway addresses the molecular restraint on cytoskeletal remodeling, while plasticity-oriented approaches address the capacity of neural circuits to adapt. Together, these goals frame potential interventions for repair after central nervous system injury.